VIPoma pathophysiology

Revision as of 00:46, 22 December 2017 by Madhu Sigdel (talk | contribs)
Jump to navigation Jump to search

VIPoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating VIPoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

VIPoma pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of VIPoma pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on VIPoma pathophysiology

CDC on VIPoma pathophysiology

VIPoma pathophysiology in the news

Blogs on VIPoma pathophysiology

Directions to Hospitals Treating VIPoma

Risk calculators and risk factors for VIPoma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Madhu Sigdel M.B.B.S.[2]Parminder Dhingra, M.D. [3]

Overview

A VIPoma is a rare tumor of the non-beta cells of the pancreas that results in the overproduction of the hormone vasoactive intestinal peptide (VIP). On microscopic histopathological analysis, findings of VIPoma are composition of uniform, small to intermediate-sized cells in clusters, nests, and trabecular growth patterns with hyperchromatic nuclei and scant cytoplasm.[1][2]

Pathophysiology

  • VIPoma causes cells in the pancreas to produce high levels of a hormone called vasoactive intestinal peptide (VIP).
  • Vasoactive intestinal peptide hormone stimulates secretions from the intestine and pancreas, inhibits gastric acid secretion, increases glycogenolysis, causes hypercalcemia and relaxes sphincters and circular smooth muscles of gut.
  • Vasoactive intestinal peptide (VIP) is a structural homologue of secretin.
  • Elevated serum VIP levels cause increased intestinal secretion of Na+, K+, HCO3 -, and Cl-, as well as bone resorption, vasodilation, and inhibition of gastric acid section.[2]
  • VIPomas are neuroendocrine neoplasms arising from the pancreas in 90% of the cases reported, while the remaining 10% occur in other tissues of neural crest origin.[1]
  • VIPomas originate in amine precursor uptake and decarboxylation (APUD) cells of the gastroenteropancreatic endocrine system and in adrenal or extra-adrenal neurogenic sites.[1]
  • When VIPoma is found in the pancreas, 75% of the tumors occur in the corpus and cauda, while 25% occur in the pancreatic head.[1]

Gross Pathology

On gross pathology, circumscribed, solid mass composed of tan, uniform, fleshy parenchyma are characteristic findings of VIPoma.

Microscopic Pathology

  • Histologically, a VIPoma demonstrates a composition of uniform, small to intermediate-sized cells in clusters, nests, and trabecular growth patterns with hyperchromatic nuclei and scant cytoplasm. A few nests may also exhibit psuedorosettes.
  • Immunohistochemistry of VIPoma typically demonstrates positive immunoreactivity for vasoactive intestinal peptide, cytokeratin, neuron specific enolase, chromogranin, synaptophysin, and somatostatin, with negative reactivity for S100, calcitonin, PSA, CEA, insulin, glucagon, and growth hormone.[1]

References

  1. 1.0 1.1 1.2 1.3 1.4 Natanzi, Naveed; Amini, Mazyar; Yamini, David; Nielsen, Shawn; Ram, Ramin (2009). "Vasoactive Intestinal Peptide Tumor". Scholarly Research Exchange. 2009: 1–7. doi:10.3814/2009/938325. ISSN 1687-8299.
  2. 2.0 2.1 2.2 Joyce, David L; Hong, Kelvin; Fishman, Elliot K; Wisell, Joshua; Pawlik, Timothy M (2008). "Multi-visceral resection of pancreatic VIPoma in a patient with sinistral portal hypertension". World Journal of Surgical Oncology. 6 (1): 80. doi:10.1186/1477-7819-6-80. ISSN 1477-7819.
  3. APODACA-TORREZ, Franz R.; TRIVIÑO, Marcello; LOBO, Edson José; GOLDENBERG, Alberto; TRIVIÑO, Tarcísio (2014). "Extra-pancreatic vipoma". ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo). 27 (3): 222–223. doi:10.1590/S0102-67202014000300015. ISSN 0102-6720.


Template:WikiDoc Sources